Uptick Network
GenBio, Inc. Discusses Entering the 191 Billion Dollar Anti-Inflammatory Market, Potential of Their Research, Crowdfunding Offering, and Their Strategic Partnership with Dakshidin Corp. (OTC:Pink DKSC) on The Stock Day Podcast
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:09:59
- More information
Informações:
Synopsis
The Stock Day Podcast welcomed GenBio, Inc. and Dakshidin Corp (OTC Pink: DKSC)("the Company"). Giles Tilley, Managing Director of GenBio Inc. an early-stage Biotechnology Company with unrivaled (and possibly unique) research expertise based on an unexpected yet vitally important medical research breakthrough - described by the US scientific team as “never seen before”, and Dakshidin Corp. CEO, Chris Haigh, joined Stock Day host Everett Jolly.
